8-K Announcements
6Material company update
Apr 8, 2026·SEC
Material company update
Mar 9, 2026·SEC
Material company update
Mar 6, 2026·SEC
Vicarious Surgical Inc.(RBOT)Earnings, Financials & Key Ratios
RBOT•NYSE
$0.42
$3M mkt cap·Price updated May 6, 2026
AboutVicarious Surgical Inc. engages in developing and selling single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. It offers Vicarious System, a single-incision surgical robot for ventral hernia repair. The company was incorporated in 2014 and is headquartered in Waltham, Massachusetts.Show more
- Revenue$0
- EBITDA-$50M+23.1%
- Net Income-$50M+20.6%
- EPS (Diluted)-8.45+21.2%
- ROE-177.51%-103.1%
- ROIC-116.17%-28.8%
- Debt/Equity0.79+168.2%
RBOT Key Insights
Vicarious Surgical Inc. (RBOT) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Trading at only 0.3x book value
✗Weaknesses
- ✗Profits declining 31.3% over 5 years
- ✗Weak Piotroski F-Score: 1/9
- ✗Weak momentum: RS Rating 1 (bottom 1%)
- ✗Trading more than 30% below 52-week high
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
RBOT Price & Volume
Vicarious Surgical Inc. (RBOT) stock price & volume — 10-year historical chart
Loading chart...
RBOT Growth Metrics
Vicarious Surgical Inc. (RBOT) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years-
TTM-
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM31.65%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM35.41%
Return on Capital
10 Years-73.01%
5 Years-73.91%
3 Years-92.57%
Last Year-134.61%
RBOT Peer Comparison
Vicarious Surgical Inc. (RBOT) competitors in Surgical tools, endoscopy, and robotics — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 ISRG | 160.44B | 451.73 | 57.40 | 20.51% | 28.15% | 16.89% | 0.02 | |
 MASI | 9.35B | 178.49 | -63.74 | -27.1% | 4.9% | 9.08% | 0.78 | |
 SSYS | 790.28M | 9.25 | -5.44 | -8.79% | -22.69% | -15.29% | 0.04 | |
 TMCI | 122.98M | 1.93 | -2.08 | 1.59% | -27.74% | -67.56% | 0.16 | |
 SYK | 111.96B | 292.33 | 34.80 | 11.16% | 12.92% | 15.04% | 0.66 | |
 MDT | 99.48B | 77.60 | 21.50 | 3.62% | 13% | 9.45% | 0.59 | |
 NVCR | 1.88B | 16.50 | -13.52 | 8.28% | -25.66% | -50.82% | 0.85 | |
 GMED | 12.07B | 89.22 | 22.76 | 16.65% | 18.3% | 12.4% | 0.03 |
Compare RBOT vs Peers
Vicarious Surgical Inc. (RBOT) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
RBOT Income Statement
Vicarious Surgical Inc. (RBOT) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 1.85M | 2.11M | 1.43M | 643K |
| COGS % of Revenue | - | - | - | - | - | - | - | - |
| Gross Profit | 0▲ 0% | 0▲ 0% | 0▲ 0% | 0▲ 0% | -1.85M▲ 0% | -2.11M▼ 13.6% | -1.43M▲ 32.4% | -643K▲ 0% |
| Gross Margin % | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | -13.65% | 32.37% | - |
| Operating Expenses | 9.78M | 12.98M | 38.22M | 80.08M | 78.81M | 64.45M | 49.54M | 42.08M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 2.3M | 3.19M | 16.16M | 36.18M | 33.09M | 26.4M | 17.37M | 13.5M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - |
| Research & Development | 7.48M | 9.8M | 22.06M | 43.9M | 47.58M | 40.16M | 33.6M | 29.23M |
| R&D % of Revenue | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | -1.85M | -2.11M | -1.43M | -643K |
| Operating Income | -9.78M▲ 0% | -12.98M▼ 32.7% | -38.22M▼ 194.4% | -80.08M▼ 109.5% | -80.67M▼ 0.7% | -66.56M▲ 17.5% | -50.97M▲ 23.4% | -42.72M▲ 0% |
| Operating Margin % | - | - | - | - | - | - | - | - |
| Operating Income Growth % | - | -32.73% | -194.36% | -109.5% | -0.73% | 17.49% | 23.42% | - |
| EBITDA | -9.68M | -12.83M | -37.91M | -78.97M | -78.81M | -64.45M | -49.54M | -41.67M |
| EBITDA Margin % | - | - | - | - | - | - | - | - |
| EBITDA Growth % | - | -32.53% | -195.5% | -108.32% | 0.2% | 18.23% | 23.13% | 35.14% |
| D&A (Non-Cash Add-back) | 104K | 157K | 316K | 1.11M | 1.85M | 2.11M | 1.43M | 1.06M |
| EBIT | -9.78M | -12.98M | -35.12M | 5.36M | -71.05M | -63.22M | -50.97M | -34.78M |
| Net Interest Income | 469 | 110K | -69K | 1.24M | 4.4M | 3.29M | 973K | 527K |
| Interest Income | 469 | 113K | 20K | 1.44M | 4.43M | 3.29M | 973K | 527K |
| Interest Expense | 0 | 3K | 89K | 200K | 25K | 0 | 0 | 0 |
| Other Income/Expense | 469K | 110K | 3.02M | 85.23M | 9.6M | 3.33M | 786K | 606K |
| Pretax Income | -9.31M▲ 0% | -12.88M▼ 38.2% | -35.21M▼ 173.5% | 5.16M▲ 114.6% | -71.07M▼ 1478.1% | -63.22M▲ 11.0% | -50.18M▲ 20.6% | -42.12M▲ 0% |
| Pretax Margin % | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -9.31M▲ 0% | -12.88M▼ 38.2% | -35.21M▼ 173.5% | 5.16M▲ 114.6% | -71.07M▼ 1478.1% | -63.22M▲ 11.0% | -50.18M▲ 20.6% | -42.12M▲ 0% |
| Net Margin % | - | - | - | - | - | - | - | - |
| Net Income Growth % | - | -38.23% | -173.45% | 114.65% | -1478.15% | 11.04% | 20.63% | 31.65% |
| Net Income (Continuing) | -9.31M | -12.88M | -35.21M | 5.16M | -71.07M | -63.22M | -50.18M | -42.12M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.70▲ 0% | -3.76▼ 121.2% | -10.92▼ 190.4% | 1.21▲ 111.1% | -14.60▼ 1306.6% | -10.72▲ 26.6% | -8.45▲ 21.2% | -6.29▲ 0% |
| EPS Growth % | - | -121.18% | -190.43% | 111.08% | -1306.61% | 26.58% | 21.18% | 35.41% |
| EPS (Basic) | -1.70 | -3.76 | -10.92 | 1.27 | -14.70 | -10.72 | -8.45 | - |
| Diluted Shares Outstanding | 5.47M | 3.42M | 3.22M | 4.25M | 4.87M | 5.89M | 5.94M | 6.7M |
| Basic Shares Outstanding | 5.46M | 3.42M | 3.22M | 4.29M | 4.83M | 5.89M | 5.94M | 6.7M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - |
RBOT Balance Sheet
Vicarious Surgical Inc. (RBOT) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 15.73M | 17.13M | 178.37M | 120.4M | 100.95M | 51.7M | 11.58M | 5.15M |
| Cash & Short-Term Investments | 15.48M | 16.87M | 173.51M | 116.21M | 98.18M | 49.1M | 9.79M | 3.68M |
| Cash Only | 2.16M | 16.87M | 173.51M | 116.21M | 52.82M | 9.74M | 2.57M | 1.41M |
| Short-Term Investments | 13.32M | 0 | 0 | 0 | 45.35M | 39.36M | 7.22M | 2.27M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - |
| Other Current Assets | 255K | 0 | 0 | 4.2M | 2.78M | 2.6M | 1.79M | 1.47M |
| Total Non-Current Assets | 630K | 663K | 3.31M | 19.89M | 18.91M | 16.02M | 8M | 7.43M |
| Property, Plant & Equipment | 482K | 445K | 2.25M | 18.86M | 17.86M | 15.04M | 7.03M | 6.73M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | 0.00x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 345.19M | 0 | 936K | 0 | 0 | 0 | 936K |
| Other Non-Current Assets | 148K | -344.97M | 1.05M | 92K | 1.05M | 985K | 965K | 2.66M |
| Total Assets | 16.36M▲ 0% | 17.79M▲ 8.7% | 181.68M▲ 921.4% | 140.29M▼ 22.8% | 119.86M▼ 14.6% | 67.72M▼ 43.5% | 19.58M▼ 71.1% | 12.59M▲ 0% |
| Asset Turnover | - | - | - | - | - | - | - | 0.00x |
| Asset Growth % | - | 8.7% | 921.36% | -22.78% | -14.56% | -43.5% | -71.08% | -268.02% |
| Total Current Liabilities | 622K | 814K | 6.25M | 8.39M | 7.28M | 7.67M | 3.9M | 3.35M |
| Accounts Payable | 203K | 373K | 1.5M | 1.73M | 1.26M | 1.17M | 894K | 1.03M |
| Days Payables Outstanding | - | - | - | - | 247.66 | 201.99 | 228.99 | 505.21 |
| Short-Term Debt | 47K | 47K | 647K | 16K | 0 | 0 | 1.95M | 1.16M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 372K | 291K | 0 | 0 | 4.06M | 3.97M | 1.06M | 1.16M |
| Current Ratio | 25.30x | 21.04x | 28.56x | 14.35x | 13.87x | 6.74x | 2.97x | 2.97x |
| Quick Ratio | 25.30x | 21.04x | 28.56x | 14.35x | 13.87x | 6.74x | 2.97x | 2.97x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 111K | 121K | 92.34M | 20.85M | 14.62M | 13.35M | 5.84M | 5.67M |
| Long-Term Debt | 111K | 63K | 691K | 0 | 0 | 0 | 0 | 5.67M |
| Capital Lease Obligations | 0 | 0 | 0 | 14.83M | 13.79M | 12.57M | 5.84M | 29.25M |
| Deferred Tax Liabilities | 0 | -12.07M | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 58K | 91.65M | 6.02M | 830K | 787K | 0 | 1.39M |
| Total Liabilities | 733K | 935K | 98.59M | 29.25M | 21.89M | 21.02M | 9.74M | 9.02M |
| Total Debt | 158K | 110K | 1.34M | 15.69M | 14.83M | 13.79M | 7.79M | 6.82M |
| Net Debt | -2M | -16.76M | -172.17M | -100.52M | -37.99M | 4.05M | 5.22M | 5.42M |
| Debt / Equity | 0.01x | 0.01x | 0.02x | 0.14x | 0.15x | 0.30x | 0.79x | 0.79x |
| Debt / EBITDA | - | - | - | - | - | - | - | -0.16x |
| Net Debt / EBITDA | - | - | - | - | - | - | - | -0.13x |
| Interest Coverage | - | -4328.33x | -394.58x | 26.79x | -2841.84x | - | - | - |
| Total Equity | 15.63M▲ 0% | 16.85M▲ 7.8% | 83.09M▲ 393.0% | 111.05M▲ 33.6% | 97.97M▼ 11.8% | 46.7M▼ 52.3% | 9.84M▼ 78.9% | 3.57M▲ 0% |
| Equity Growth % | - | 7.81% | 393.03% | 33.64% | -11.78% | -52.33% | -78.93% | -312.02% |
| Book Value per Share | 2.86 | 4.92 | 25.80 | 26.15 | 20.13 | 7.93 | 1.66 | 0.53 |
| Total Shareholders' Equity | 15.63M | 16.85M | 83.09M | 111.05M | 97.97M | 46.7M | 9.84M | 3.57M |
| Common Stock | 1K | 9K | 12K | 13K | 17K | 17K | 17K | 17K |
| Retained Earnings | -18.72M | -31.59M | -66.8M | -61.64M | -132.71M | -195.94M | -246.12M | -253.45M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | -329.22M | 0 | 0 | 10K | 50K | 4K | -2K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
RBOT Cash Flow Statement
Vicarious Surgical Inc. (RBOT) cash flow — operating, investing & free cash flow history
| Line item | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -8.71M | -12.04M | -33.3M | -61.21M | -62.3M | -49.96M | -45.08M | -45.08M |
| Operating CF Margin % | - | - | - | - | - | - | - | - |
| Operating CF Growth % | - | -38.19% | -176.61% | -83.83% | -1.79% | 19.82% | 9.77% | 62.72% |
| Net Income | -9.31M | -12.88M | -35.21M | 5.16M | -71.07M | -63.22M | -50.18M | -42.12M |
| Depreciation & Amortization | 104K | 157K | 316K | 1.11M | 1.85M | 2.11M | 1.43M | 1.24M |
| Stock-Based Compensation | 337K | 448K | 3.69M | 12.26M | 13.27M | 11.9M | 8.13M | 2.17M |
| Deferred Taxes | 0 | 188.07K | -3.08M | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 64K | -188.07K | 21K | -83.1M | -5.61M | -150K | 451K | 4.27M |
| Working Capital Changes | 98K | 232K | 955K | 3.36M | -746K | -594K | -4.91M | -5.11M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 0 | 170K | 1.13M | 135K | -473K | -96K | -272K | 8.34K |
| Cash from Investing | -1.85M | 13.2M | -1.29M | -5.35M | -45.78M | 6.86M | 32.15M | 32.53M |
| Capital Expenditures | -246K | -120K | -1.29M | -5.35M | -1.67M | -180K | -132K | -135.71K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 344.99M | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - |
| Other Investing | -1.6M | 13.32K | 0 | 0 | 0 | 0 | 0 | 133K |
| Cash from Financing | 10M | 13.52M | 192.16M | 9.14M | 44.7M | 8K | 5.76M | 5.59M |
| Debt Issued (Net) | -27K | -48K | 1.3M | -1.4M | -16K | 0 | 525K | 526.24K |
| Equity Issued (Net) | 0 | 13.52M | 0 | 10M | 47.24M | 8K | 5.24M | 5.23M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 10.03M | 43K | 190.86M | 542K | -2.53M | 0 | 0 | -167.77K |
| Net Change in Cash | -559K▲ 0% | 14.68M▲ 2726.3% | 157.58M▲ 973.3% | -57.42M▼ 136.4% | -63.39M▼ 10.4% | -43.09M▲ 32.0% | -7.17M▲ 83.4% | -1.45M▲ 0% |
| Free Cash Flow | -8.96M▲ 0% | -12.16M▼ 35.7% | -34.59M▼ 184.5% | -66.56M▼ 92.5% | -63.98M▲ 3.9% | -50.14M▲ 21.6% | -45.21M▲ 9.8% | -39.68M▲ 0% |
| FCF Margin % | - | - | - | - | - | - | - | - |
| FCF Growth % | - | -35.74% | -184.48% | -92.45% | 3.89% | 21.63% | 9.83% | 16.35% |
| FCF per Share | -1.64 | -3.55 | -10.74 | -15.67 | -13.14 | -8.52 | -7.61 | -7.61 |
| FCF Conversion (FCF/Net Income) | 0.94x | 0.93x | 0.95x | -11.87x | 0.88x | 0.79x | 0.90x | 0.94x |
| Interest Paid | 2K | 3K | 36K | 41K | 1K | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
RBOT Key Ratios
Vicarious Surgical Inc. (RBOT) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -79.27% | -70.45% | 5.31% | -68.01% | -87.4% | -177.51% | -333.19% |
| Return on Invested Capital (ROIC) | -141.86% | - | - | -171.62% | -90.16% | -116.17% | -116.17% |
| Debt / Equity | 0.01x | 0.02x | 0.14x | 0.15x | 0.30x | 0.79x | 0.79x |
| Interest Coverage | -4328.33x | -394.58x | 26.79x | -2841.84x | - | - | - |
| FCF Conversion | 0.93x | 0.95x | -11.87x | 0.88x | 0.79x | 0.90x | 0.94x |
RBOT SEC Filings & Documents
Vicarious Surgical Inc. (RBOT) SEC filings — annual & quarterly reports (10-K, 10-Q)
RBOT Frequently Asked Questions
Vicarious Surgical Inc. (RBOT) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Vicarious Surgical Inc. (RBOT) grew revenue by 0.0% over the past year. Growth has been modest.
Vicarious Surgical Inc. (RBOT) reported a net loss of $42.1M for fiscal year 2025.
Dividend & Returns
Vicarious Surgical Inc. (RBOT) has a return on equity (ROE) of -177.5%. Negative ROE indicates the company is unprofitable.
Vicarious Surgical Inc. (RBOT) had negative free cash flow of $39.7M in fiscal year 2025, likely due to heavy capital investments.
Explore More RBOT
Vicarious Surgical Inc. (RBOT) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates